Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Advances in Pharmacology (San Diego, Calif.)|October 14, 2014
Drug abuse and the neurovascular unitRichard D Egleton, Thomas AbbruscatoCurrent Topics in Developmental Biology|October 24, 2007
Pathophysiology of the blood-brain barrier: animal models and methodsBrian T Hawkins, Richard D EgletonJournal of Neuroscience Methods|September 27, 2005
Fluorescence imaging of blood-brain barrier disruptionBrian T Hawkins, Richard D EgletonNeurorx : the Journal of the American Society for Experimental Neurotherapeutics|February 18, 2005
Development of neuropeptide drugs that cross the blood-brain barrierRichard D Egleton, Thomas P DavisTrends in Pharmacological Sciences|February 12, 2008
Nicotinic acetylcholine receptors in cancer: multiple roles in proliferation and inhibition of apoptosisRichard D Egleton, Kathleen C Brown, Piyali DasguptaPharmacology & Therapeutics|December 10, 2008
Angiogenic activity of nicotinic acetylcholine receptors: implications in tobacco-related vascular diseasesRichard D Egleton, Kathleen C Brown, Piyali DasguptaBrain Research|June 24, 2004
Mannitol opening of the blood-brain barrier: regional variation in the permeability of sucrose, but not 86Rb+ or albuminRachel C Brown, Richard D Egleton, Thomas P DavisPeptides|May 5, 2015
Peptides at the blood brain barrier: Knowing me knowing youThomas P Davis, Thomas J Abbruscato, Richard D EgletonAmerican Journal of Physiology. Heart and Circulatory Physiology|February 15, 2005
Modulation of cerebral microvascular permeability by endothelial nicotinic acetylcholine receptorsBrian T Hawkins, Richard D Egleton, Thomas P DavisBiomolecules|March 28, 2026
Nicotine-Mediated Alterations in Exosome Content: Implications for Stroke and Neurological DysfunctionChristopher Grahe, Richard D Egleton, Nalini Santanam, et al.Pageof 3